Efficacy and safety of low-dose ipragliflozin, a selective sodium glucose transporter 2 inhibitor, in patients with type 2 diabetes mellitus.

Abstract

Objective Few studies have focused on the efficacy and safety of low-dose of selective sodium glucose transporter 2 (SGLT2) inhibitors in patients with type 2 diabetes. Ipragliflogin is an SGLT2 inhibitor licensed in Japan for administration at standard (50mg/day) or high (100mg/day) doses to treat type 2 diabetes mellitus in Japan. However, little is known about low-dose ipragliflozin (25mg/day) on safety and efficacy on the glucose control parameters and the other metabolic parameters. We study the efficacy and safety of low-dose ipragliflozin for the treatment of diabetic patients. Methods 14 individuals with type 2 diabetes mellitus who had not used SGLT2 inhibitors were recruited and given low-dose ipragliflozin (25mg/day). After 24 weeks, glucose control parameters and the other metabolic parameters were evaluated. Results All patients completed the study without any complications. Compared to baseline, HbA1c, fasting glucose, and HOMA-β significantly improved, and in terms of metabolic parameters, body weight, systolic blood pressure, LDL-cholesterol, and BNP significantly improved. In addition, urinary albumin excretion significantly reduced among the patients with microalbuminuria, and for one patient with macroalbuminuria, urinary albumin excretion decreased to half compared to baseline. Conclusion Low-dose ipragliflozin (25mg/day) is useful for treatment for type 2 diabetes mellitus on not only glycemic control but also the other metabolic disorders without complications of SGLT2 inhibitors.

Authors and Affiliations

Ichiro Abe

Keywords

Related Articles

Study of pedicle morphometry of the lumbar vertebrae

The growing need of various orthopaedic procedures to vertebral column like posterior spinal instrumentation and transpedicular screw fixation of the spine demands accurate knowledge of measurements of the various parts...

Correlation between squamous blepharitis and scalp dandruff

Background Blepharitis is one of the most common ocular conditions for which the patient visits the ophthalmologist. This study was conducted with objective to determine the correlation between Squamous Blepharitis and S...

Selective serotonin reuptake inhibitors induced serotonin syndrome – A case report

Serotonin syndrome also known as serotonin toxicity is a potentially life threatening syndrome that is precipitated due to excess serotonin within CNS. It results in variety of mental, autonomic and neuromuscular changes...

Formulation and characterization of paracetamol, diclofenac sodium and domperidone lozenges

A combination of paracetamol, diclofenac and domperidone were formulated in the lozenge form to make available the immediate release of the drugs in fever, pain and nausea conditions. Lozenges are a form of dosage forms...

Antihyperglycemic and hypoglycemic effect of portulaca quadrifida linn

The hypoglycemic effect of ethanolic extract of Portulaca quadrifida was investigated on glucose loaded and streptozotocin induced diabetic rats. The blood glucose levels were measured at 0, 1, 2 and 3 h after the treatm...

Download PDF file
  • EP ID EP419806
  • DOI -
  • Views 53
  • Downloads 0

How To Cite

Ichiro Abe (2016). Efficacy and safety of low-dose ipragliflozin, a selective sodium glucose transporter 2 inhibitor, in patients with type 2 diabetes mellitus.. International Journal of Allied Medical Sciences and Clinical Research, 4(3), 376-382. https://europub.co.uk/articles/-A-419806